MGTX
MeiraGTx Holdings plc
There isn't enough reported data to score MGTX yet.
MGTX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Under pressure | |
| Strong |
MGTX's profitability and balance sheet are currently strong, but its cash flow is under pressure. There isn't enough data to rate its revenue.
MGTX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 11x | $8.79 | โ |
| Cheap | 13x | $10.39 | +18% |
| Fair | 15x | $12.22 | +39% |
| Expensive | 19x | $15.50 | +76% |
Historical ranges are pointers, not guarantees.
MGTX's PE is 11x, but its earnings don't support one, so it isn't a reliable read right now.
MGTX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect MGTX's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
MGTX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.80 | +$2.90 |
| Q2 2026 | $0.71 | +$2.74 |
| Q1 2026 | -$1.48 | +$0.83 |
| Q4 2025 | -$1.42 | +$0.70 |
| Q3 2025 | -$2.10 | -$0.87 |
| Q2 2025 | -$2.03 | -$0.61 |
| Q1 2025 | -$2.31 | -$1.12 |
| Q4 2024 | -$2.12 | -$0.63 |
MGTX has returned to profit: it earned $0.80 per share over the past year, after losing money the year before.
MGTX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.8M | +1074% |
| Q2 2026 | $321.4M | +8609% |
| Q4 2025 | $75.4M | +252% |
| Q3 2025 | $410K | -96% |
| Q2 2025 | $3.7M | +1209% |
| Q3 2024 | $10.9M | +114% |
| Q2 2024 | $282K | -92% |
| Q1 2024 | $697K | -79% |
MGTX's revenue is growing: $5M last quarter, up 1074% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1036% | +10196 points |
| Q2 2026 | 76% | +1290 points |
| Q1 2026 | -13931% | N/A |
| Q4 2025 | 35% | +182 points |
| Q3 2025 | -11232% | -10865 points |
| Q2 2025 | -1214% | +15066 points |
| Q4 2024 | -147% | N/A |
| Q3 2024 | -367% | +275 points |
MGTX's operating margin was โ1036% last quarter, up 10196 points from the same quarter a year ago.
MGTX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$26.3M | -$13.5M |
| Q2 2026 | -$38.9M | +$6.3M |
| Q1 2026 | $15.8M | +$54.3M |
| Q4 2025 | $46.4M | +$70.9M |
| Q3 2025 | -$12.8M | +$12.9M |
| Q2 2025 | -$45.2M | -$24.4M |
| Q1 2025 | -$38.5M | -$119K |
| Q4 2024 | -$24.5M | -$6.9M |
MGTX has burned cash in almost every quarter: โ$3M over the past year, against โ$121M the year before.
MGTX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
MGTX has more cash than debt.
MGTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 6.8 | Oversold |
MGTX's weekly RSI is 38 (neutral) and its Stochastic is 7 (oversold).
MGTX PE vs Healthcare Sector
| Metric | MGTX | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 26x | 57% below |
MGTX is trading at 11x earnings, a 57% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
MGTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.77 | 10% below |
| 20 week MA | $11.8 | 26% below |
| 50 week MA | $9.90 | 11% below |
| 100 week MA | $8.49 | 3.5% above |
| 200 week MA | $7.11 | 24% above |
MGTX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 24% above its 200-week average.
MGTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.1 | $16.4 | -18% |
| 2021 | $16.4 | $22.4 | +36% |
| 2022 | $22.4 | $6.01 | -73% |
| 2023 | $6.01 | $7.02 | +17% |
| 2024 | $7.02 | $6.21 | -12% |
| 2025 | $6.21 | $7.97 | +28% |
| 2026 YTD | $7.97 | $8.79 | +10% |
MGTX has finished lower in three of the last six years. It's up 10% so far in 2026.